Oxford Science Enterprises Holdings Ii Limited investment portfolio

Amber Therapeutics Holdings Limited develops a bio‑electronic neuromodulation platform, the Picostim system, to treat mixed urinary incontinence in women. Its focus is on delivering a breakthrough therapy that restores normal physiological function for this condition.

BibliU operates a digital platform that delivers e‑textbooks, monographs and courseware to universities, colleges and academic libraries, allowing students and staff to access learning materials online. The service integrates with institutional systems and publisher agreements to provide cost‑effective, on‑demand content for higher‑education institutions.